Drug Shortage Report for PREVYMIS
| Report ID | 210157 |
| Drug Identification Number | 02469405 |
| Brand name | PREVYMIS |
| Common or Proper name | Letermovir for injection |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LETERMOVIR |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 x Vial |
| ATC code | J05AX |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-02-05 |
| Actual start date | 2024-01-31 |
| Estimated end date | 2024-04-05 |
| Actual end date | 2024-03-27 |
| Shortage status | Resolved |
| Updated date | 2024-03-28 |
| Company comments | PREVYMIS SFI 240MG VIAL, PREVYMIS 240MG 4X7TAB & PREVYMIS 480MG 4X7TAB formats remain available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v25 | 2024-03-28 | French | Compare |
| v24 | 2024-03-27 | French | Compare |
| v23 | 2024-03-27 | English | Compare |
| v22 | 2024-03-14 | French | Compare |
| v21 | 2024-03-14 | English | Compare |
| v20 | 2024-02-01 | English | Compare |
| v19 | 2024-01-31 | French | Compare |
| v18 | 2024-01-31 | English | Compare |
| v17 | 2024-01-18 | French | Compare |
| v16 | 2024-01-18 | English | Compare |
| v15 | 2024-01-04 | French | Compare |
| v14 | 2024-01-04 | English | Compare |
| v13 | 2024-01-04 | French | Compare |
| v12 | 2024-01-04 | English | Compare |
| v11 | 2023-12-15 | French | Compare |
| v10 | 2023-12-15 | English | Compare |
| v9 | 2023-12-08 | French | Compare |
| v8 | 2023-12-08 | English | Compare |
| v7 | 2023-12-01 | French | Compare |
| v6 | 2023-12-01 | English | Compare |